Investigation of nicotinamide as more than an anti-phosphorus drug in chronic hemodialysis patients: a single-center, double-blind, randomized, placebo-controlled trial - Concepedia

Concepedia

Publication | Open Access

Investigation of nicotinamide as more than an anti-phosphorus drug in chronic hemodialysis patients: a single-center, double-blind, randomized, placebo-controlled trial

DOI Full Paper Access

15

Citations

12

References

2020

Year

Xiangyang Liu, Jingrui Yao, Rong Xu, Linxin Xu, Yue‐Feng Zhang, Shan Lu, Zhiheng Xing, Liping Fan, Zhonghua Qin, Bei Sun

Annals of Translational Medicine

Abstract

NAM can not only further decrease the phosphorus level but also reduce the FGF23 level and slow down the descending rate of Klotho in chronic hemodialysis patients.

References

	Year	Citations

Page 1